CompletedPhase 1

W-SUDs for COVID-19

United States180 participantsStarted 2020-06-22

Plain-language summary

The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic. This study that will test the comparative efficacy of the mobile-app based substance use disorder program to reduce substance use relative to a wait list control condition, and explore between group differences on quality of life indices as well as retention and engagement during COVID-19.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All genders aged 18-65 years * Access to a smartphone * Available and committed to engage with app and complete assessments * Be willing to provide email address (as this is how assessment incentives will be distributed), * Literate in English (as W-SUDs conversational and video materials will be in English). Exclusion Criteria: * Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of this population) * History of severe drug/alcohol use * History of opioid misuse without medication-assisted treatment * Suicide attempt within the past year * Opioid overdose within the past year

What they're measuring

Change in Number of Substance Use Occasions in the Past 30 Days From Baseline to Post-treatment at 8 Weeks

Timeframe: Change from Baseline to Post-treatment at 8 weeks

Trial details

NCT IDNCT04460027

SponsorWoebot Health

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2020-11-30

Results submitted2022-07-19

View on ClinicalTrials.gov More Substance Use Disorders trials